https://www.selleckchem.com/pr....oducts/slf1081851-hy
glycated hemoglobin (HbA1c). Limitations related to sample size and selection were identified along with a fair level of interstudy heterogeneity. Based on the evidence evaluated, the utility of salivary fructosamine as a noninvasive marker to screen and diagnose patients with diabetes is doubtful. The overall level of evidence was low (III and the risk of bias was determined to be high. Further evidence in the form of large-scale well-controlled studies is needed prior to recommending salivary fructosamine as a nonin
Like
Comment
Share
